Face Sculptor delivers consistent natural-looking injectables through two trusted nurses, Cheska and Chiara, who prioritize honest guidance and refuse unnecessary upsells. The family-owned clinic in Mississauga has built a loyal following with warm service, a polished pink-aesthetic space, and transparent aftercare support.
One dissatisfied client reported quick product fade and questioned brand authenticity, citing better results elsewhere. Most praise centers on result longevity, skill at asymmetry correction, and the team's willingness to pause treatments for optimal outcomes. Clients describe driving long distances to return.
Last verified 2026-08-12
As listed on Google.
Credentials claimed:Canadian Board of Aesthetic Medicine
As published by the business on its own website; not independently verified.
Dr. Tohn and medical esthetician Ana lead a well-organized Mississauga clinic where consultations are thorough and results visible. Patients consistently praise the calm environment, transparent guidance on treatments (injectables, microneedling, mole removal), and genuine care from front-desk to provider.
Patients consistently experience fast scheduling and professional care from named surgeons and staff who explain procedures clearly and follow through with aftercare. One patient encountered insufficient anesthesia, missed infection signs, and improper wound cleaning at the first dressing, though later nursing care recovered the experience. Most cite the clean, welcoming atmosphere and ability to avoid provincial wait times as key strengths.
Most patients praise Dr. Ejaz and Dr. Ammara Ghumman for calm, attentive care and smooth minor procedures with minimal pain and clear aftercare. The clinic feels clean, organized, and responsive to concerns. However, multiple reviewers report feeling pressured into unnecessary procedures with misleading claims about cost and OHIP eligibility. Quoted prices for lipoma and cyst removal were substantially higher than elsewhere. Trust issues arise when clinical judgment appears profit-driven rather than patient-first.
Last updated 2026-08-12